K. Kelly

Body dysmorphic disorder in outpatients with major depression.

M. Fava, A. Nierenberg, J. Rosenbaum, 2002, Journal of affective disorders.

The thyrotropin response to thyrotropin‐releasing hormone as a predictor of response to treatment in depressed outpatients

M. Fava, J. Rosenbaum, M. Otto, 1992, Acta psychiatrica Scandinavica.

Nortriptyline for treatment-resistant depression.

M. Fava, A. Nierenberg, J. Alpert, 2003, The Journal of clinical psychiatry.

Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.

J. Rosenbaum, J. Biederman, M. Pollack, 1989, The Journal of clinical psychiatry.

Use of clonidine in the prevention and management of neonatal abstinence syndrome

W. Mackendrick, J. Leikin, M. Wahl, 2009, Clinical toxicology.

A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: Comparing patients who recently discontinued an ssri with those on no recent antidepressant treatment

M. Fava, J. Rosenbaum, D. Mischoulon, 2004, Depression and anxiety.